AI assistant
Sending…
METLIFE INC — Director's Dealing 2017
Mar 3, 2017
29995_dirs_2017-03-03_d58624a0-9d04-424d-bc4c-ffd6c0012ac5.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: METLIFE INC (MET)
CIK: 0001099219
Period of Report: 2017-03-01
Reporting Person: Townsend Christopher G (President, Asia)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2017-03-01 | Common Stock | M | 3904 | — | Acquired | 3904 | Direct |
| 2017-03-01 | Common Stock | D | 3904 | $54.33 | Disposed | 0 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2017-03-01 | Restricted Units (Cash-Payable) | $ | M | 3904 | Disposed | Common Stock (3904) | Direct |
Footnotes
F1: Each Restricted Unit is the contingent right to receive cash equal to the closing price of one share of MetLife, Inc. common stock on the vesting date.
F2: The Restricted Units vest in three equal installments on the first business day of March 2017, 2018 and 2019. The requisite certification that MetLife, Inc. met specified financial goals took place earlier.
More from METLIFE INC
Notice of Dividend Amount
2026
May 15
Regulatory Filings
2026
May 6
Annual Report
2026
Apr 29
Regulatory Filings
2026
Apr 7
Major Shareholding Notification
2026
Mar 27
Regulatory Filings
2026
Mar 20
Regulatory Filings
2026
Mar 20
Regulatory Filings
2026
Mar 20
Regulatory Filings
2026
Mar 20
Director's Dealing
2026
Mar 19